Edition:
India

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

6.41USD
2:29am IST
Change (% chg)

$0.01 (+0.16%)
Prev Close
$6.40
Open
$6.48
Day's High
$6.58
Day's Low
$6.29
Volume
16,626
Avg. Vol
27,011
52-wk High
$11.11
52-wk Low
$4.03

Latest Key Developments (Source: Significant Developments)

Foamix Q2 loss per share $0.27
Wednesday, 10 Aug 2016 

Foamix Pharmaceuticals Ltd : Q2 loss per share $0.27 . Q2 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S . Foamix reports second quarter 2016 financial results and provides business update .Q2 revenue $752,000 versus $109,000.  Full Article

Foamix names Dr Stanley Hirsch chairman, and Dr Dalia Megiddo member of board
Monday, 16 May 2016 

Foamix Pharmaceuticals Ltd : Hirsch replaces meir eini, who is retiring from board but will continue as co's chief innovation officer .Foamix names dr. Stanley hirsch as chairman, and dr. Dalia megiddo as a member of the board of foamix pharmaceuticals.  Full Article

Foamix reports Q1 loss per share $0.15
Tuesday, 10 May 2016 

Foamix Pharmaceuticals Ltd : Foamix reports first quarter 2016 financial results and provides business update . Q1 loss per share $0.15 .Q1 revenue $745,000 versus $448,000.  Full Article

BRIEF-Foamix Announces Positive Results From Late Stage Acne Treatment Study

* FOAMIX ANNOUNCES POSITIVE RESULTS FROM PHASE 3 OPEN-LABEL SAFETY EXTENSION EVALUATING FMX-101 TOPICAL MINOCYCLINE FOAM FOR TREATMENT UP TO 1 YEAR Source text for Eikon: Further company coverage: